Medicenna Therapeutics Corp

NASDAQ:MDNA  
1.59
-0.15 (-8.62%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Medicenna Therapeutics Corp Stock, NASDAQ:MDNA

2 Bloor Street West, 7th floor, Toronto, Ontario M4W 3E2
Canada
Phone: +1.416.648.5555
Number of Employees: 14

Description

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.